Characteristic N Beta 95% CI1 p-value
Delta LV Mass Index 279 0.00 -0.01, 0.01 0.8
PQ-interval 279 0.00 0.00, 0.01 0.3
LVEF Biplane 279 0.01 -0.01, 0.03 0.3
LVEDV biplane 279 0.00 -0.01, 0.00 0.3
LVESV biplane 279 -0.01 -0.02, 0.00 0.2
LV stroke volume 279 0.00 -0.02, 0.01 0.7
LV cardiac output 205 0.00 -0.01, 0.01 0.8
Relative wall thickness 279 0.87 -1.6, 3.4 0.5
AV peakPG 279 0.02 0.00, 0.03 0.009
AV Vmax 279 0.61 0.25, 0.97 <0.001
LAFB (Left anterior fascicular block) 279
    No
    Yes -0.42 -2.2, 1.4 0.6
Delta LAVI 279 0.02 0.00, 0.03 0.015
LV internal diastolic diameter 279 -0.03 -0.07, 0.02 0.3
Interventricular septum diameter 279 -0.06 -0.21, 0.08 0.4
TAPSE 279 0.03 -0.03, 0.10 0.3
Delta E/e' Selfmade 279 -0.21 -0.24, -0.17 <0.001
LVOT Vmax 279 0.37 -1.0, 1.7 0.6
Previous Cardiac Surgery 279
    No
    Yes -0.65 -1.4, 0.08 0.080
RBBB 279
    No
    Yes -1.6 -2.5, -0.57 0.002
LBBB 279
    No
    Yes -0.37 -1.6, 0.86 0.6
Atrial fibrillation/Atrial flutter 279
    No
    Yes 0.06 -0.59, 0.72 0.8
Heart faillure 279
    No
    Yes -0.37 -1.0, 0.27 0.3
Rhythm 279
    Sinus rhythm
    Atrial fibrillation -0.05 -0.83, 0.74 >0.9
    Pacemaker rhythm -0.62 -2.1, 0.85 0.4
Heart Rate 279 -0.01 -0.03, 0.01 0.4
QRS-interval 279 -0.01 -0.02, 0.00 0.2
Ureum 279 0.00 -0.06, 0.05 >0.9
Natrium 279 0.00 -0.09, 0.08 >0.9
Kalium 279 -0.10 -0.77, 0.57 0.8
BMI 279 0.00 -0.06, 0.05 >0.9
NT-proBNP 279 0.00 0.00, 0.00 0.7
Implanted Valve Size (mm) 279 -0.01 -0.10, 0.08 0.8
Active Malignancy 279
    No
    Yes 0.09 -0.93, 1.1 0.9
Severe Liver Disease/Cirrhosis 279
    No
    Yes -0.36 -5.3, 4.6 0.9
Hostile Chest 279
    No
    Yes 2.6 -0.29, 5.4 0.078
AV block 279
    no block
    first degree 0.87 -0.03, 1.8 0.059
    second degree 0.66 -4.3, 5.6 0.8
    third degree -0.63 -3.5, 2.2 0.7
Valve Type 278
    BE
    SE 0.41 -0.19, 1.0 0.2
TAVI number 279 0.00 0.00, 0.00 0.8
Age at Time of the Procedure 279 -0.03 -0.07, 0.01 0.2
Gender 279
    Female
    Male 0.32 -0.27, 0.91 0.3
Diabetes 279
    No
    Yes 0.03 -0.61, 0.68 >0.9
Hypertension 279
    No
    Yes -0.29 -0.89, 0.30 0.3
Coronary Artery Disease 279
    No
    Yes 0.17 -0.42, 0.76 0.6
COPD 279
    No
    Yes 0.02 -0.66, 0.70 >0.9
Previous CVA 279
    No
    Yes 0.36 -0.50, 1.2 0.4
Peripheral Vascular Disease 279
    No
    Yes 0.25 -0.56, 1.1 0.6
Previous Pacemaker 279
    No
    Yes 0.33 -0.84, 1.5 0.6
Porcelain Aorta 279
    No
    Yes 0.23 -0.95, 1.4 0.7
Severe Pulmonary Hypertension 279
    No
    Yes 0.24 -1.8, 2.3 0.8
Hb 279 -0.05 -0.33, 0.24 0.8
Kreatinine 279 0.00 -0.01, 0.01 0.7
eGFR 279 0.01 -0.01, 0.02 0.4
E mean/lat/sep Pre 279 -0.74 -0.83, -0.64 <0.001
LV Mass Index Pre 279 -0.01 -0.02, 0.00 0.2
E-velocity 279 -0.01 -0.02, 0.00 0.004
E/e' Selfmade Pre 279 0.12 0.07, 0.16 <0.001
AV VTI 279 0.01 0.00, 0.03 0.046
LVOT VTI 279 0.05 0.00, 0.10 0.076
AVA VTI Pre 279 -0.39 -0.93, 0.15 0.2
LVOT 279 -0.04 -0.19, 0.11 0.6
Access Route 279
    Transfemoral
    Transapical 0.26 -0.84, 1.4 0.6
    Direct-aortic -0.25 -1.1, 0.63 0.6
diff 279 -0.12 -0.34, 0.11 0.3
LAVI biplane/A4C/A2C Pre 279 0.00 -0.01, 0.02 0.8
Delta E/e' 147 -0.15 -0.19, -0.11 <0.001
Atrial Fibrillation Classification 73
    Paroxysmal
    Persistent -0.10 -2.6, 2.4 >0.9
    Permanent 0.00 -1.6, 1.6 >0.9
Heart Faillure Classification 78
    HFpEF
    HFrEF -0.52 -2.7, 1.7 0.6
    HFmrEF -0.51 -3.2, 2.2 0.7
    Decompensated AoS 0.05 -1.7, 1.8 >0.9
    Unknown -0.06 -2.9, 2.8 >0.9
Coronary status at time of TAVI procedure 109
    0-VD
    1-VD -0.28 -1.7, 1.2 0.7
    2-VD -0.23 -1.9, 1.4 0.8
    3-VD -1.2 -3.1, 0.63 0.2
Left Main Stenosis (>50%) 148
    No
    Yes -5.5 -8.2, -2.8 <0.001
Previous Myocardial Infarction 152
    No
    Yes -0.37 -1.4, 0.67 0.5
Previous PCI 153
    No
    Yes -0.12 -1.1, 0.82 0.8
Previous AVR 74
    No
    Yes 0.69 -0.84, 2.2 0.4
Which Aortic Valve Surgery 13
    Bioprothesis (unstented)
    Bioprothese (stented) 0.82 -3.1, 4.8 0.7
    TAVI-Valve 2.0 -3.3, 7.4 0.4
Previous CABG 74
    No
    Yes -0.16 -1.4, 1.0 0.8
E/e' mean/lat/sep Pre 175 0.06 0.01, 0.10 0.015
LV GLS 177 -0.04 -0.13, 0.04 0.3
LV internal systolic diameter 187 -0.01 -0.06, 0.04 0.7
e' septal 166 -0.63 -0.75, -0.52 <0.001
e' lateral 162 -0.33 -0.45, -0.22 <0.001
e' mean 132 -0.51 -0.66, -0.35 <0.001
A-velocity 179 0.00 0.00, 0.01 0.3
E/A ratio 166 -0.90 -1.6, -0.20 0.012
E/e' septal 147 0.03 -0.01, 0.07 0.14
E/e' lateral 146 0.04 -0.01, 0.09 0.2
E/e' average 118 0.04 -0.01, 0.09 0.15
LA end-systolic volume (biplane) 127 0.01 -0.01, 0.03 0.5
TR peak velocity 184 -0.19 -0.72, 0.35 0.5
TR peak pressure gradient 184 -0.01 -0.03, 0.01 0.5
RV internal diastolic diameter 169 -0.03 -0.10, 0.05 0.5
Pulmonary artery systolic pressure 136 -0.01 -0.03, 0.02 0.6
RA end-systolic volume (A4C) 178 0.00 -0.01, 0.02 0.7
AV meanPG 179 0.02 -0.01, 0.05 0.2
LA area 184 0.02 -0.06, 0.10 0.6
RA area 178 0.00 -0.06, 0.07 >0.9
1 CI = Confidence Interval